Neuropediatrics 2015; 46(01): 044-048
DOI: 10.1055/s-0034-1389897
Short Communication
Georg Thieme Verlag KG Stuttgart · New York

Overlap Phenotype between CMT1A and Hereditary Neuropathy with Liability to Pressure Palsies Caused by the Novel Small In-frame Deletion c.407_418del12 in PMP22 Gene

Katharina Vill
1   Dr. v. Hauner Children Hospital, Ludwig-Maximilian University of Munich, Germany
,
Marius Kuhn
2   Genetikum Center for Human Genetics, Neu-Ulm, Germany
,
Dieter Gläser
2   Genetikum Center for Human Genetics, Neu-Ulm, Germany
,
Wolfgang Müller-Felber
1   Dr. v. Hauner Children Hospital, Ludwig-Maximilian University of Munich, Germany
› Author Affiliations
Further Information

Publication History

17 April 2014

01 July 2014

Publication Date:
29 September 2014 (online)

Abstract

We report monozygotic twins, who presented with a clinical picture of Charcot–Marie–Tooth disease type 1 (CMT1) with bilateral foot drop, pes cavus, thoracic kyphosis, and scoliosis. Hereditary neuropathy with liability to pressure palsies (HNPP) showed up in one of them. Neurography showed demyelinating neuropathy, typical for CMT1, and transient conduction block in the ulnar nerve correlating with clinical ulnar palsy due to minor mechanical stress in only one of them. Genetic analysis revealed novel small de novo deletion c.407_418del12 in the PMP22 gene. Our patient shows the rarely reported combination of CMT1A and HNPP, caused by an in-frame deletion in the PMP22 gene. HNPP is in the majority of cases correlated with heterozygous deletion of the whole PMP22 gene or other mutations leading to functional haploinsufficiency. The cases give further evidence that pathogenesis of HNPP is not completely understood and can obviously result from existence of a defective protein, too. The intrafamiliar phenotypic variability, even in monozygotic twins, confirms the well-known fact that factors apart from genetics contribute to the clinical course.

 
  • References

  • 1 van Paassen BW, van der Kooi AJ, van Spaendonck-Zwarts KY, Verhamme C, Baas F, de Visser M. PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies. Orphanet J Rare Dis 2014; 9: 38
  • 2 Lupski JR, de Oca-Luna RM, Slaugenhaupt S , et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991; 66 (2) 219-232
  • 3 Raeymaekers P, Timmerman V, Nelis E , et al. The HMSN Collaborative Research Group. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). Neuromuscul Disord 1991; 1 (2) 93-97
  • 4 Chance PF, Alderson MK, Leppig KA , et al. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 1993; 72 (1) 143-151
  • 5 Behse F, Buchthal F, Carlsen F, Knappeis GG. Hereditary neuropathy with liability to pressure palsies. Electrophysiological and histopathological aspects. Brain 1972; 95 (4) 777-794
  • 6 Oda K, Miura H, Shibasaki H , et al. Hereditary pressure-sensitive neuropathy: demonstration of “tomacula” in motor nerve fibers. J Neurol Sci 1990; 98 (2-3) 139-148
  • 7 Verhamme C, van Schaik IN, Koelman JH, de Haan RJ, de Visser M. The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study. Brain 2009; 132 (Pt 12) 3252-3262
  • 8 Andersson PB, Yuen E, Parko K, So YT. Electrodiagnostic features of hereditary neuropathy with liability to pressure palsies. Neurology 2000; 54 (1) 40-44
  • 9 Boerkoel CF, Inoue K, Reiter LT, Warner LE, Lupski JR. Molecular mechanisms for CMT1A duplication and HNPP deletion. Ann N Y Acad Sci 1999; 883: 22-35
  • 10 Russo M, Laurá M, Polke JM , et al. Variable phenotypes are associated with PMP22 missense mutations. Neuromuscul Disord 2011; 21 (2) 106-114
  • 11 Gabreëls-Festen AA, Gabreëls FJ, Joosten EM, Vingerhoets HM, Renier WO. Hereditary neuropathy with liability to pressure palsies in childhood. Neuropediatrics 1992; 23 (3) 138-143
  • 12 Shaibani A, Gooch C, Harati Y. Moving toes and myoclonus associated with hereditary neuropathy with liability to pressure palsy (HNPP). Muscle Nerve 1997; 20 (7) 881-883
  • 13 Ohkoshi N, Kohno Y, Hayashi A, Wada T, Shoji S. Acute vocal cord paralysis in hereditary neuropathy with liability to pressure palsies. Neurology 2001; 56 (10) 1415
  • 14 Verma A. Neuropathic scapuloperoneal syndrome (Davidenkow's syndrome) with chromosome 17p11.2 deletion. Muscle Nerve 2005; 32 (5) 668-671
  • 15 Kalfakis N, Panas M, Karadima G, Floroskufi P, Kokolakis N, Vassilopoulos D. Hereditary neuropathy with liability to pressure palsies emerging during vincristine treatment. Neurology 2002; 59 (9) 1470-1471
  • 16 Cruz-Martínez A, Bort S, Arpa J, Palau F. Hereditary neuropathy with liability to pressure palsies (HNPP) revealed after weight loss. Eur Neurol 1997; 37 (4) 257-260
  • 17 Korn-Lubetzki I, Argov Z, Raas-Rothschild A, Wirguin I, Steiner I. Family with inflammatory demyelinating polyneuropathy and the HNPP 17p12 deletion. Am J Med Genet 2002; 113 (3) 275-278
  • 18 Chance PF. Inherited focal, episodic neuropathies: hereditary neuropathy with liability to pressure palsies and hereditary neuralgic amyotrophy. Neuromolecular Med 2006; 8 (1-2) 159-174
  • 19 Stockton DW, Meade RA, Netscher DT , et al. Hereditary neuropathy with liability to pressure palsies is not a major cause of idiopathic carpal tunnel syndrome. Arch Neurol 2001; 58 (10) 1635-1637
  • 20 Taioli F, Cabrini I, Cavallaro T, Acler M, Fabrizi GM. Inherited demyelinating neuropathies with micromutations of peripheral myelin protein 22 gene. Brain 2011; 134 (Pt 2) 608-617
  • 21 Koutsis G, Pandraud A, Polke JM , et al. Novel peripheral myelin protein 22 (PMP22) micromutations associated with variable phenotypes in Greek patients with Charcot-Marie-Tooth disease. Brain 2012; 135 (Pt 8) e217 , 1–6, author reply e218, 1–2
  • 22 Database IPNM . Available at: http://www.molgen.ua.ac.be/CMTMutations/home/IPN.cfm . Accessed June 26, 2014
  • 23 de Vries SD, Verhamme C, van Ruissen F , et al. The phenotype of the Gly94fsX222 PMP22 insertion. J Peripher Nerv Syst 2011; 16 (2) 113-118
  • 24 Saporta AS, Sottile SL, Miller LJ, Feely SM, Siskind CE, Shy ME. Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Ann Neurol 2011; 69 (1) 22-33
  • 25 Li J, Parker B, Martyn C, Natarajan C, Guo J. The PMP22 gene and its related diseases. Mol Neurobiol 2013; 47 (2) 673-698
  • 26 Silander K, Meretoja P, Juvonen V , et al. Spectrum of mutations in Finnish patients with Charcot-Marie-Tooth disease and related neuropathies. Hum Mutat 1998; 12 (1) 59-68
  • 27 Sambuughin N, de Bantel A, McWilliams S, Sivakumar K. Deafness and CMT disease associated with a novel four amino acid deletion in the PMP22 gene. Neurology 2003; 60 (3) 506-508
  • 28 Zhang F, Khajavi M, Connolly AM, Towne CF, Batish SD, Lupski JR. The DNA replication FoSTeS/MMBIR mechanism can generate genomic, genic and exonic complex rearrangements in humans. Nat Genet 2009; 41 (7) 849-853
  • 29 Mersiyanova IV, Ismailov SM, Polyakov AV , et al. Screening for mutations in the peripheral myelin genes PMP22, MPZ and Cx32 (GJB1) in Russian Charcot-Marie-Tooth neuropathy patients. Hum Mutat 2000; 15 (4) 340-347
  • 30 Houlden H, Reilly MM. Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease. Neuromolecular Med 2006; 8 (1-2) 43-62
  • 31 Naef R, Adlkofer K, Lescher B, Suter U. Aberrant protein trafficking in Trembler suggests a disease mechanism for hereditary human peripheral neuropathies. Mol Cell Neurosci 1997; 9 (1) 13-25
  • 32 Adlkofer K, Frei R, Neuberg DH, Zielasek J, Toyka KV, Suter U. Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy. J Neurosci 1997; 17 (12) 4662-4671
  • 33 Kleopa KA, Georgiou DM, Nicolaou P , et al. A novel PMP22 mutation Ser22Phe in a family with hereditary neuropathy with liability to pressure palsies and CMT1A phenotypes. Neurogenetics 2004; 5 (3) 171-175
  • 34 Lenssen PP, Gabreëls-Festen AA, Valentijn LJ , et al. Hereditary neuropathy with liability to pressure palsies. Phenotypic differences between patients with the common deletion and a PMP22 frame shift mutation. Brain 1998; 121 (Pt 8) 1451-1458
  • 35 Garcia CA, Malamut RE, England JD, Parry GS, Liu P, Lupski JR. Clinical variability in two pairs of identical twins with the Charcot-Marie-Tooth disease type 1A duplication. Neurology 1995; 45 (11) 2090-2093
  • 36 Braathen GJ, Sand JC, Russell MB. Symptomatic Charcot-Marie-Tooth? A pair of concordant monozygotic twins. Acta Neurol Scand 2006; 114 (6) 403-406